Results 331 to 340 of about 681,334 (361)

Editorial: Community series in adenosine pathways in cancer immunity and immunotherapy, volume II. [PDF]

Front Immunol
Fu J, Antonioli L, Zheng X, El-Far AH.
europepmc   +1 more source

Targeting the Adenosine-Mediated Metabolic Immune Checkpoint with Engineered Probiotic for Enhanced Chemo-Immunotherapy. [PDF]

Adv Sci (Weinh)
Wang J, Wang J, Yu Z, Wen H, Zhao C, Zhong J, Xiao C, Li Y, Xu J, Wang J, Mao ZW, Xia W.   +11 more
europepmc   +1 more source

Current and Emerging Insights into the Causes, Immunopathogenesis, and Treatment of Cutaneous Squamous Cell Carcinoma. [PDF]

Cancers (Basel)
Anderson R, Mkhize NM, Kgokolo MMC, Steel HC, Rossouw TM, Anderson L, Rapoport BL.   +6 more
europepmc   +1 more source

Dynamic Velocity Tracking in the Left-Ventricular Outflow Track Using Four-Dimensional 4D Flow for the Assessment of Left Ventricular Outflow Track Obstruction. [PDF]

Clin Case Rep
Sawh C, Garg P.
europepmc   +1 more source

Functional profiling reveals a non-enzymatic role of NUDT5 in repressing purinede novosynthesis

Lin JG, Nguyen T, Marques AMC, Scrofani L, Daum D, Bauer LG, Cheng C, D’Angelo L, Sanchez J, Bueschl C, Buphamalai P, Siklos M, Genger J, Hofstaetter G, Runggatscher K, Guertl B, Liu Y, Hansen J, Koren A, Froese DS, Rosenblatt DS, Klavins K, Bergthaler A, Menche J, Hannich JT, Sdelci S, Huber KVM, Kubicek S.   +27 more
europepmc   +1 more source

Getting to know adenosine deaminase 2 deficiency inside and out.

J Allergy Clin Immunol
Ehlers L, Meyts I.
europepmc   +1 more source

Adenosine and Adenosine Receptors [PDF]

American Journal of Respiratory Cell and Molecular Biology, 1990
In the last decade, there has been renewed interest in extracellular signaling by adenosine and adenine nucleotides. The potent cardiovascular effects of these agents were originally described by Drury and Szent-Gy6rgyi in 1929 (1). This report was followed by a flurry of interest in the use of adenosine as an antihypertensive agent, which subsided ...
openaire   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Adenosine and adenosine receptors in colorectal cancer

International Immunopharmacology, 2020
CD39 (nucleoside triphosphate diphosphohydrolase) and Ecto-5-nucleotidase (CD73) have been recognized as important factors mediating various pathological and physiological responses in the tumor microenvironment. Elevated expression of CD73 and CD39 is correlated with the over-production of adenosine in the tumor region.
A.V. Sevbitov, Makwan Peydaveisi, Ali Masjedi, Farnaz Hajizadeh, Sima Heydarzedeh Asl, Farhad Jadidi-Niaragh, Ghasem Ghalamfarsa, Fariba Karoon Kiani   +7 more
openaire   +2 more sources

Interstitial adenosine with dipyridamole: effect of adenosine receptor blockade and adenosine deaminase

American Journal of Physiology-Heart and Circulatory Physiology, 1992
Dipyridamole is proposed to increase coronary blood flow (CBF) by inhibition of adenosine uptake into cells, resulting in an increase in interstitial fluid (ISF) adenosine and an adenosine-mediated vasodilation. The purpose of this study was to determine the changes in CBF and ISF adenosine, inosine, and hypoxanthine during dipyridamole infusion in ...
D. G. L. Van Wylen, T. Wang, R. M. Mentzer   +2 more
openaire   +3 more sources

Is adenosine deaminase involved in adenosine transport?

Medical Hypotheses, 1990
The hypothesis that adenosine metabolizing enzymes may have a key role in the transport of adenosine is discussed. The enhancement of adenosine transport by inhibitors of adenosine deaminase (the enzyme which deaminates adenosine to inosine) and the ecto-localization of adenosine deaminase suggest a contribution of the enzyme in taking up nucleosides ...
Josep J. Centelles, Rafael Franco
openaire   +3 more sources